AU2003220928A1 - Cyclic hemiacetal derivative and use thereof - Google Patents
Cyclic hemiacetal derivative and use thereofInfo
- Publication number
- AU2003220928A1 AU2003220928A1 AU2003220928A AU2003220928A AU2003220928A1 AU 2003220928 A1 AU2003220928 A1 AU 2003220928A1 AU 2003220928 A AU2003220928 A AU 2003220928A AU 2003220928 A AU2003220928 A AU 2003220928A AU 2003220928 A1 AU2003220928 A1 AU 2003220928A1
- Authority
- AU
- Australia
- Prior art keywords
- cyclic hemiacetal
- hemiacetal derivative
- lower alkyl
- alkyl group
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 Cyclic hemiacetal Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 102000007590 Calpain Human genes 0.000 abstract 1
- 108010032088 Calpain Proteins 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/22—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002072762 | 2002-03-15 | ||
| JP2002-072762 | 2002-03-15 | ||
| PCT/JP2003/003122 WO2003078415A1 (en) | 2002-03-15 | 2003-03-14 | Cyclic hemiacetal derivative and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003220928A1 true AU2003220928A1 (en) | 2003-09-29 |
Family
ID=28035193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003220928A Abandoned AU2003220928A1 (en) | 2002-03-15 | 2003-03-14 | Cyclic hemiacetal derivative and use thereof |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7202274B2 (enExample) |
| EP (1) | EP1489076B1 (enExample) |
| JP (2) | JPWO2003078415A1 (enExample) |
| KR (1) | KR101016593B1 (enExample) |
| CN (1) | CN1297548C (enExample) |
| AT (1) | ATE404548T1 (enExample) |
| AU (1) | AU2003220928A1 (enExample) |
| DE (1) | DE60322856D1 (enExample) |
| ES (1) | ES2307915T3 (enExample) |
| WO (1) | WO2003078415A1 (enExample) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06504547A (ja) * | 1990-12-28 | 1994-05-26 | ジョージア・テック・リサーチ・コーポレーション | ペプチドケトアミド、ケト酸およびケトエステル |
| EP0641563A4 (en) | 1992-05-20 | 1995-04-19 | Taisho Pharmaceutical Co Ltd | MEDICINAL AGAINST CATARACT AND ITS PRODUCTION. |
| JP2825172B2 (ja) | 1992-07-10 | 1998-11-18 | 東京エレクトロン株式会社 | 減圧処理装置および減圧処理方法 |
| JPH08104685A (ja) * | 1993-09-03 | 1996-04-23 | Takeda Chem Ind Ltd | ラクトール誘導体、その製造法および用途 |
| NO943210L (no) * | 1993-09-03 | 1995-03-06 | Takeda Chemical Industries Ltd | Laktolderivater, deres fremstilling og anvendelse |
| US5498616A (en) * | 1994-11-04 | 1996-03-12 | Cephalon, Inc. | Cysteine protease and serine protease inhibitors |
| TW394764B (en) * | 1995-02-14 | 2000-06-21 | Mitsubishi Chemcal Corp | Oxygen-containing heterocyclic derivatives |
| JPH09169752A (ja) | 1995-02-14 | 1997-06-30 | Mitsubishi Chem Corp | 含酸素複素環誘導体 |
| ATE239698T1 (de) | 1995-10-25 | 2003-05-15 | Senju Pharma Co | Angiogenese hemmer |
| WO1998004539A1 (en) * | 1996-07-29 | 1998-02-05 | Mitsubishi Chemical Corporation | Oxygenic heterocyclic derivatives |
-
2003
- 2003-03-14 JP JP2003576421A patent/JPWO2003078415A1/ja not_active Ceased
- 2003-03-14 DE DE60322856T patent/DE60322856D1/de not_active Expired - Lifetime
- 2003-03-14 AU AU2003220928A patent/AU2003220928A1/en not_active Abandoned
- 2003-03-14 CN CNB038061104A patent/CN1297548C/zh not_active Expired - Fee Related
- 2003-03-14 US US10/507,831 patent/US7202274B2/en not_active Expired - Fee Related
- 2003-03-14 EP EP03712708A patent/EP1489076B1/en not_active Expired - Lifetime
- 2003-03-14 ES ES03712708T patent/ES2307915T3/es not_active Expired - Lifetime
- 2003-03-14 AT AT03712708T patent/ATE404548T1/de not_active IP Right Cessation
- 2003-03-14 WO PCT/JP2003/003122 patent/WO2003078415A1/ja not_active Ceased
- 2003-03-14 KR KR1020047014523A patent/KR101016593B1/ko not_active Expired - Fee Related
-
2010
- 2010-04-22 JP JP2010099186A patent/JP2010189424A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7202274B2 (en) | 2007-04-10 |
| EP1489076A4 (en) | 2005-12-21 |
| US20050119499A1 (en) | 2005-06-02 |
| ES2307915T3 (es) | 2008-12-01 |
| EP1489076B1 (en) | 2008-08-13 |
| EP1489076A1 (en) | 2004-12-22 |
| KR20050006130A (ko) | 2005-01-15 |
| ATE404548T1 (de) | 2008-08-15 |
| WO2003078415A1 (en) | 2003-09-25 |
| KR101016593B1 (ko) | 2011-02-22 |
| JP2010189424A (ja) | 2010-09-02 |
| CN1642933A (zh) | 2005-07-20 |
| JPWO2003078415A1 (ja) | 2005-07-14 |
| CN1297548C (zh) | 2007-01-31 |
| DE60322856D1 (enExample) | 2008-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0210030A (pt) | Derivado de fenilpiridinacarbonilpiperazina | |
| WO2005061458A3 (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| IL158485A (en) | Spiropyrazole compounds | |
| DK1385514T3 (da) | Spiroinden- og spiroindanforbindelser | |
| YU82303A (sh) | Analozi nociceptina | |
| ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| SI1975164T1 (sl) | Oktahidrobenzimidazolonske spojine kot analgetiki | |
| EP1019389A4 (en) | EPOTHILONE DERIVATIVES | |
| WO2002085291A3 (en) | Nociceptin analogs | |
| WO2005063786A3 (en) | Process for fluorocytidine derivatives | |
| WO2002083616A1 (en) | α-SUBSTITUTED φ-ARYLFATTY ACID DERIVATIVE | |
| DK1031556T3 (da) | 2-phenoxyanilinderivater | |
| DK1209151T3 (da) | 4-substituerede piperidinderivativer | |
| EP1398306A3 (en) | A (1'R, 2'S, 5'R)-3-l-Menthoxyalkan-1-ol cooling sensate | |
| DE60230781D1 (en) | Reverse hydroxamsäurederivate | |
| WO2004099130A3 (en) | 1,2-diarylimidazoles useful as inhibitors of cox | |
| WO2004024727A3 (en) | Synthesis of indolizines | |
| EP1489076A4 (en) | CYCLIC HEMIACETAL DERIVATIVE AND USE THEREOF | |
| AU2003248059A1 (en) | NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF | |
| WO2003082837A1 (en) | Hydroxymorpholinone derivative and medicinal use thereof | |
| EP1693421A4 (en) | benzimidazolone | |
| WO2003051365A3 (fr) | Utilisation de composes de la famille des benzamides comme agent immunosuppresseur |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |